Add to Calendar 3/27/2019 8:15:00 AM 3/28/2019 2:30:00 PM 2019 Annual Meeting: State of Possible Conference
This year’s Annual Meeting is now the State of Possible Conference where we'll celebrate what’s possible in our industry and for patients today that wasn’t five or 10 years ago. The two-day event will draw over 600 industry leaders from Massachusetts and beyond to debate the most pressing challenges facing the life sciences to ensure we can continue this incredible success. Attendees will hear from the brightest minds through keynotes, panel discussions and 15-minute Possible Talks, inspiring and engaging content in the style of a TED Talk. We'll also have a networking reception, the State of Possible Celebration, immediately following Day 1 of the conference, where we'll have great food, drinks, a DJ. Attendees will also have access to the exhibits at the Museum of Science. Join us as we celebrate the State of Possible!
 

If you haven’t attended our Annual Meeting before, it is the premier east coast life sciences conference and this year’s event is better than ever. With speakers like Katrine Bosley, John Maraganore, Jeremy Levin, George Church, and more, we have some of the brightest names in biotech talking about the issues impacting our industry. See our incredible lineup of speakers and topics below. Online registration closes at noon on Tuesday, March 26th. Walk-in registrations will be available on-site. 

Royal Sonesta Boston, 40 Edwin Land Blvd Cambridge MA 02142

This year’s Annual Meeting is now the State of Possible Conference where we'll celebrate what’s possible in our industry and for patients today that wasn’t five or 10 years ago. The two-day event will draw over 600 industry leaders from Massachusetts and beyond to debate the most pressing challenges facing the life sciences to ensure we can continue this incredible success. Attendees will hear from the brightest minds through keynotes, panel discussions and 15-minute Possible Talks, inspiring and engaging content in the style of a TED Talk. We'll also have a networking reception, the State of Possible Celebration, immediately following Day 1 of the conference, where we'll have great food, drinks, a DJ. Attendees will also have access to the exhibits at the Museum of Science. Join us as we celebrate the State of Possible!
 

If you haven’t attended our Annual Meeting before, it is the premier east coast life sciences conference and this year’s event is better than ever. With speakers like Katrine Bosley, John Maraganore, Jeremy Levin, George Church, and more, we have some of the brightest names in biotech talking about the issues impacting our industry. See our incredible lineup of speakers and topics below. Online registration closes at noon on Tuesday, March 26th. Walk-in registrations will be available on-site. 

Head of the DNA Editing Platform, Beam Therapeutics
Nicole Gaudelli received her B.S. degree in biochemistry from Boston College in May of 2006. While at Boston College she conducted research under the guidance of Prof. Steve Bruner to elucidate the enzymatic mechanisms of an aminotransferase involved in neocrazinostatin biosynthesis and a non-heme iron oxygenase involved in vancomycin assembly. She then joined the laboratory of Prof. Craig Townsend at Johns Hopkins University where she studied a non-ribosmal peptide synthetase (NRPS) implicated in the biosynthesis of the β-lactam antibiotic nocardicin. In her doctoral work she elucidated the mechanism through which monobactam anitbiotics are biosynthesized. She next pursued postdoctoral work at Harvard University in the laboratory of Professor David R. Liu where she expanded the capabilities of base-editing technology by creating an adenine base editor (ABE), through 7 rounds of evolution and engineering, which cleanly converts A•T base pairs to G•C base pairs in a programmable manner, with low indel %, and without double-stranded DNA breaks. She joined Beam Therapeutics where she is the Head of the DNA Editing Platform in order to further expand and apply base editing technology to human genetic diseases. Nicole was a recipient of the 2018 American Chemical Society's “Talented 12” award and also recognized as a 2018 STAT Wunderkind.

Brought to you by